Due to COVID-19, new study enrollment is being assessed on a case by case basis. If you have any questions please call our central phone number at 616-391-1230.
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Protocol | AFT-25 COMET |
---|---|
Cancer Type: | Low Risk DCIS |
Fast Facts |
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for Low Risk DCIS: A Phase III Prospective Randomized Trial
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA1181 |
---|---|
Cancer Type: | Neoadjuvant Breast |
Fast Facts |
Preoperative THP and postoperative HP in patients who achieve a pathologic complete response
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1418 Adjuvant |
---|---|
Cancer Type: | Triple(-); ypT1or ypN(+) |
Fast Facts |
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
Protocol | SWOG S1706 |
---|---|
Cancer Type: | Inflammatory Breast Cancer |
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | CCTG MA.39 Adjuvant |
---|---|
Cancer Type: | LOW RISK NODE POSITIVE BREAST CANCER |
Fast Facts |
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Protocol | NRG BR003 Adjuvant |
---|---|
Cancer Type: | Triple-Negative Invasive Breast Cancer |
Fast Facts |
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG BR002 |
---|---|
Cancer Type: | Newly Oligometastatic Breast Cancer |
Fast Facts |
A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Protocol | NRG-BR004 |
---|---|
Cancer Type: | Metastatic Breast Cancer |
Fast Facts |
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | ACCRU 2018-01 |
---|---|
Cancer Type: | Untreated Solid Tumors |
Fast Facts |
Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors
Protocol | PDM 9846 |
---|---|
Cancer Type: | Tissue Procurement |
Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A011202 Adjuvant |
---|---|
Cancer Type: | Breast Cancer |
Fast Facts |
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Protocol | Alliance A211601 |
---|---|
Cancer Type: | ABC Companion |
Fast Facts |
Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion to Alliance Study A011502 |
Protocol | Alliance A221505 Adjuvant |
---|---|
Cancer Type: | Breast Cancer |
Fast Facts |
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Protocol | EAZ171 |
---|---|
Cancer Type: | peripheral neuropathy in African American women |
Fast Facts |
Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women
Protocol | SWOG S1501 CC cardiac tox |
---|---|
Cancer Type: | METASTATIC HER-2+ BREAST CANCER |
Fast Facts |
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer, Phase III
Protocol | SWOG S1703 |
---|---|
Cancer Type: | METASTATIC BREAST CANCER |
Fast Facts |
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer
Protocol | SWOG S1714 |
---|---|
Cancer Type: | Multiple Cancer control |
Fast Facts |
A Prospective Observational Cohort Study to Develop A Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
Protocol | URCC 16070 CC nausea |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Treatment of Refractory Nausea
Protocol | URCC 18007 |
---|---|
Cancer Type: | Cancer-Related Fatigue |
Fast Facts |
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue
Protocol | URCC 19085 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial
Protocol | WF 97116 CC cog impair |
---|---|
Cancer Type: | Breast Cancer |
Fast Facts |
A Phase III Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors With Cognitive Impairment
Protocol | WF 97415 |
---|---|
Cancer Type: | Breast Cancer |
Fast Facts |
Understanding and Predicting Breast Cancer Events after Treatment (UPBEAT)
Protocol | Alliance A231901CD |
---|---|
Cancer Type: | CCDR |
Fast Facts |
IMPROVING PATIENT-CENTERED COMMUNICATION IN BREAST CANCER: A RCT OF A SHARED DECISION ENGAGEMENT SYSTEM (SHARES)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA1151 (TMIST) |
---|---|
Cancer Type: | Screening |
Fast Facts |
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.